APBI 2016

Ongoing and future projects

(1) RTOG/NCI Phase II trial protocol : • Re-irradiation with EBRT • Eligible pts.: Unicentric LR ≤ 3 cm, no skin involvement, clear margins, 0-3 + LNs • Accrual goal: 61 pts. • Primary end-point: ≥ G3 side effects occuring within 1 year

(2) GEC-ESTRO Breast Cancer WG :

• Re-irradiation with multi-catheter HDR/PDR BT • Multicentric retrospective match-paired analysis is pending • Prospective Phase II trial

University Hospital Erlangen